William C DeWolf
Overview
Explore the profile of William C DeWolf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
998
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steinberg R, Packiam V, Thomas L, Brooks N, Vitale A, Mott S, et al.
Urol Oncol
. 2021 Jun;
40(1):9.e1-9.e7.
PMID: 34092482
Introduction: Repeat BCG induction remains an option for select non-muscle invasive bladder cancer (NMIBC) patients who fail initial therapy. Alternative salvage intravesical regimens such as Gemcitabine and Docetaxel (Gem/Doce) have...
2.
Steinberg R, Thomas L, Brooks N, Mott S, Vitale A, Crump T, et al.
J Urol
. 2019 Dec;
203(5):902-909.
PMID: 31821066
Purpose: Rescue intravesical therapies for patients with bacillus Calmette-Guérin failure nonmuscle invasive bladder cancer remain a critical focus of ongoing research. Sequential intravesical gemcitabine and docetaxel therapy has shown safety...
3.
Abello A, DeWolf W, Das A
Neurourol Urodyn
. 2018 Nov;
38(1):305-309.
PMID: 30407653
Aims: To describe urologic complications in patients with chronically elevated post-void residual (PVR) volumes and to evaluate other related risk factors during a long-term follow-up in patients managed conservatively. Methods:...
4.
Genega E, Rosen S, DeWolf W, Ye H
Urology
. 2016 Mar;
91:148-9.
PMID: 27020239
No abstract available.
5.
Quintana L, Ward A, Gerrin S, Genega E, Rosen S, Sanda M, et al.
Urology
. 2016 Mar;
91:143-9.
PMID: 26944351
Objective: To compare the utility of saturation core biopsy and 12-core biopsy in detecting true Gleason grades, using final pathology in prostatectomy specimens as outcome measures, with a particular interest...
6.
Kacker R, Hult M, San Francisco I, Conners W, Rojas P, DeWolf W, et al.
Asian J Androl
. 2015 Aug;
18(1):16-20.
PMID: 26306850
This report presents our experience with T therapy in a cohort of T-deficient men on active surveillance (AS) for Gleason 3 + 3 and Gleason 3 + 4 prostate cancer...
7.
San Francisco I, Rojas P, DeWolf W, Morgentaler A
BJU Int
. 2014 Jun;
114(2):229-35.
PMID: 24898919
Objective: To determine whether total testosterone and free testosterone levels predict disease reclassification in a cohort of men with prostate cancer (PCa) on active surveillance (AS). Patients And Methods: Total...
8.
9.
Delto J, Kacker R, Bubley G, DeWolf W
Clin Genitourin Cancer
. 2013 Oct;
12(1):e35-6.
PMID: 24169496
No abstract available.
10.
Costa D, Bloch B, Yao D, Sanda M, Ngo L, Genega E, et al.
Magn Reson Imaging
. 2013 Apr;
31(6):947-52.
PMID: 23602725
Objectives: To establish the value of MRI in targeting re-biopsy for undiagnosed prostate cancer despite multiple negative biopsies and determine clinical relevance of detected tumors. Materials And Methods: Thirty-eight patients...